These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21533509)

  • 1. Human DNA topoisomerase II-alpha.
    Martinchick J; Rahn M; Jolles C; Holden J
    Int J Oncol; 1997 Jun; 10(6):1229-34. PubMed ID: 21533509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.
    Lynch BJ; Guinee DG; Holden JA
    Hum Pathol; 1997 Oct; 28(10):1180-8. PubMed ID: 9343325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human deoxyribonucleic acid topoisomerases: molecular targets of anticancer drugs.
    Holden JA
    Ann Clin Lab Sci; 1997; 27(6):402-12. PubMed ID: 9433537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB1 expression and patient survival.
    Holden JA; Townsend JJ
    Mod Pathol; 1999 Dec; 12(12):1094-100. PubMed ID: 10619260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining for DNA topoisomerase IIa in Hodgkin's disease.
    Brown MS; Holden JA; Rahn MP; Perkins SL
    Am J Clin Pathol; 1998 Jan; 109(1):39-44. PubMed ID: 9426516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Topoisomerase II-alpha as a marker of cell proliferation in endocrine and other neoplasms.
    Holden JA
    Endocr Pathol; 1999 Jun; 10(2):97-102. PubMed ID: 27519213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
    Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
    Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
    Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
    Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of DNA toposiomerase I and DNA topoisomerase II-alpha in testicular seminomas.
    Coleman LW; Perkins SL; Bronstein IB; Holden JA
    Hum Pathol; 2000 Jun; 31(6):728-33. PubMed ID: 10872667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining for DNA topoisomerase II in non-Hodgkin's lymphomas.
    Holden JA; Perkins SL; Snow GW; Kjeldsberg CR
    Am J Clin Pathol; 1995 Jul; 104(1):54-9. PubMed ID: 7611182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of DNA topoisomerase II in human gastric disorders.
    Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A
    Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
    Staley BE; Samowitz WS; Bronstein IB; Holden JA
    Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors.
    van der Zee AG; de Jong S; Keith WN; Hollema H; Boonstra H; de Vries EG
    Cancer Res; 1994 Feb; 54(3):749-55. PubMed ID: 8306337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique cell membrane expression of topoisomerase-II alpha as a useful diagnostic marker of liposarcoma.
    Endo H; Hirokawa M; Ishimaru N; Tanaka Y; Yamashita M; Sakaki M; Hayashi Y; Sano T
    Pathol Int; 2004 Mar; 54(3):145-50. PubMed ID: 14989736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of DNA topoisomerase I in neoplasms of the kidney: correlation with histological grade, proliferation, and patient survival.
    Gupta D; Bronstein IB; Holden JA
    Hum Pathol; 2000 Feb; 31(2):214-9. PubMed ID: 10685636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of DNA topoisomerase I, DNA topoisomerase II-alpha, and p53 in metastatic malignant melanoma.
    Lynch BJ; Komaromy-Hiller G; Bronstein IB; Holden JA
    Hum Pathol; 1998 Nov; 29(11):1240-5. PubMed ID: 9824101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity.
    Smith K; Houlbrook S; Greenall M; Carmichael J; Harris AL
    Oncogene; 1993 Apr; 8(4):933-8. PubMed ID: 8096076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
    Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer.
    Nakopoulou L; Lazaris AC; Kavantzas N; Alexandrou P; Athanassiadou P; Keramopoulos A; Davaris P
    Pathobiology; 2000; 68(3):137-43. PubMed ID: 11174071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
    Tortora G; Ciardiello F; Damiano V; Pepe S; Bianco C; di Isernia G; Davies SL; North P; Harris AL; Hickson ID
    Clin Cancer Res; 1995 Jan; 1(1):49-56. PubMed ID: 9815886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.